Latest AstraZeneca Stories
Scientific Poster to be Presented at PEGS The Essential Protein Engineering Summit in Boston NEW YORK and CAMBRIDGE, Mass., May 4, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc.
BASEL, Switzerland, April 28, 2015 /PRNewswire/ -- At the Annual General Meeting of Syngenta AG held on April 28, 2015, the 934 shareholders representing 54.68% of the
BASEL, Switzerland, April 28, 2015 /PRNewswire/ -- -- Step change in technology to address herbicide resistance challenges -- Launch this year with peak sales potential of more
SAN FRANCISCO, April 23, 2015 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter ended March 31, 2015 on Thursday, April 30, 2015, after
BASEL, Switzerland, April 23, 2015 /PRNewswire/ -- -- Searchable, useable and shareable data on The Good Growth Plan -- Open Data Institute collaboration a first for the agriculture
GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc.
Results presented at American Association of Cancer Research Annual Meeting 2015, Philadelphia, April 18-22 PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Researchers at the Cancer Research
DALLAS, April 21, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com adds Human Papillomavirus Infections - Pipeline Review, H1 2015 and offers Human Papillomavirus Infections
DUBLIN, April 20, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zbfftz/cns_therapeutics) has announced the addition of the "CNS
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).